Evelo Biosciences (EVLO) Insider Trading & Ownership $0.0005 0.00 (-66.67%) (As of 02:47 PM ET) Add Compare Share Share Insider Trades Stock AnalysisChartCompetitorsFinancialsInsider TradesOwnershipSEC FilingsTrends Evelo Biosciences (NASDAQ:EVLO) Insider Buying and Selling ActivityCurrentInsider OwnershipPercentage1.02%Number OfInsiders Buying(Last 3 Years)1Amount OfInsider Buying(Last 3 Years)$52.50 MNumber OfInsiders Selling(Last 3 Years)5Amount OfInsider Selling(Last 3 Years)$79,065.76 Get EVLO Insider Trade Alerts Want to know when executives and insiders are buying or selling Evelo Biosciences stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily. Email Address EVLO Insider Buying and Selling by Quarter Ad Insiders Exposed917 Trades… Zero Losses?As you likely know, the “Trump bump” launched stocks to record highs after he secured his second reelection bid. Now, Trump and his team are coming to gut government regulation – and it’s going to create some incredible market opportunities. But while the masses chase large-cap tech and so-called AI stocks, a small circle of traders are using a strange but tactical method to find a pool of “hidden Trump trades.”Go here to see how you can start accessing these opportunities today Evelo Biosciences Insider and Congressional Trades History Insiders and Members of Congress Insiders Only Members of Congress Only Transaction Type Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year 2 Years 3 Years Time Frame * Start Date * End Date Export to Excel Transaction DateNameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails11/8/2023Marella ThorellCFOSell1,811$0.33$597.63 11/8/2023Mark BodmerInsiderSell3,163$0.33$1,043.79 11/8/2023Simba GillCEOSell172$0.33$56.76 9/28/2023Simba GillCEOSell1,996$3.94$7,864.24 8/8/2023Marella ThorellCFOSell2,004$9.51$19,058.04 8/8/2023Mark BodmerInsiderSell3,128$9.51$29,747.28 Get Insider Trades Delivered To Your InboxEnter your email address below to receive a concise daily summary of insider buying activity, insider selling activity and changes in hedge fund holdings. 8/8/2023Simba GillCEOSell342$9.51$3,252.42 7/11/2023Ventures Fund Iv Gene FlagshipMajor ShareholderBuy5,411,255$2.31$12,499,999.05 5/23/2023Mark BodmerInsiderSell1,128$2.80$3,158.40 5/8/2023Duncan MchaleInsiderSell3,336$2.60$8,673.60 5/8/2023Marella ThorellCFOSell1,926$2.60$5,007.60 5/8/2023Simba GillCEOSell176$2.60$457.60 1/23/2023Stephen J CarriereInsiderSell7$21.20$148.40 5/27/2022Ventures Fund Iv Gene FlagshipMajor ShareholderBuy1,369,862$29.20$39,999,970.40 (Data available from 1/1/2013 forward) EVLO Insider Trading Activity - Frequently Asked Questions Who is on Evelo Biosciences's Insider Roster? The list of insiders at Evelo Biosciences includes Duncan Mchale, Marella Thorell, Mark Bodmer, Simba Gill, Stephen J Carriere, and Ventures Fund Iv Gene Flagship. Learn more on insiders at EVLO. What percentage of Evelo Biosciences stock is owned by insiders? 1.02% of Evelo Biosciences stock is owned by insiders. Learn more on EVLO's insider holdings. Which Evelo Biosciences insiders have been buying company stock? The following insider purchased EVLO shares in the last 24 months: Ventures Fund Iv Gene Flagship ($12,499,999.05). How much insider buying is happening at Evelo Biosciences? Insiders have purchased a total of 5,411,255 EVLO shares in the last 24 months for a total of $12,499,999.05 bought. Which Evelo Biosciences insiders have been selling company stock? The following insiders have sold EVLO shares in the last 24 months: Duncan Mchale ($8,673.60), Marella Thorell ($24,663.27), Mark Bodmer ($33,949.47), Simba Gill ($11,631.02), and Stephen J Carriere ($148.40). How much insider selling is happening at Evelo Biosciences? Insiders have sold a total of 19,189 Evelo Biosciences shares in the last 24 months for a total of $79,065.76 sold. Evelo Biosciences Key ExecutivesMr. Craig R. Jalbert CIRA (Age 62)President, Secretary, Principal Executive, Financial and Accounting Officer & Director Dr. Chun Zhang Ph.D.Chief Technical Operations & Quality OfficerDr. Mark Bodmer Ph.D. (Age 66)Chief Scientific Officer and President of Research & Development Compensation: $668.8kMs. Jessica CotroneVP & Head of CommunicationsMs. Leslie Wardwell-Scott Ph.D.VP and Head of Corporate Development & Strategic IntegrationDr. Andrea Itano Ph.D.Head of ResearchDr. Duncan McHale M.D. (Age 57)MBBS, Ph.D., Chief Medical Officer Compensation: $661.97kMr. Douglas MaslinSenior Director & Immunology Clinical Lead More Insider Trading Tools from MarketBeat Related Companies CALA Insider Trades VAXX Insider Trades AMPE Insider Trades CMRA Insider Trades GNCA Insider Trades EFTR Insider Trades BTMDW Insider Trades CLVR Insider Trades FBIOP Insider Trades REGN Insider Trades Insider Tracking Tools CEO Purchases/Sales CFO Purchases/Sales Top Insider Buying Stocks Top Insider Selling Stocks Insider Trades Screener Insider Trades Newsletter Congressional Stock Trades Insider Trading By Country U.S. Insider Trading Activity Canadian Insider Trading Activity U.K. Insider Trading Activity Australia Insider Trading Activity Latest Articles Insiders Selling Into 3 Rallies: Investors Should Do the OppositeInsiders Bet Big on These Small Cap StocksHere’s Why Etsy Management Is Investing $1 Billion in BuybacksInsider Buying Signals Upside for These 3 StocksBig Buybacks Announced: 3 Stocks Insiders Are Banking On This page (NASDAQ:EVLO) was last updated on 11/21/2024 by MarketBeat.com Staff From Our PartnersThe Crypto That’s Making Wall Street SweatThe Crypto Wall Street Is Desperate to Hide It's happening now, right under everyone's radar. Big tech gian...Crypto 101 Media | SponsoredMissed Nvidia? Watch this ASAPThis little-known project that Bill Gates has been quietly working on that’s about to unleash an AI breakthrou...Brownstone Research | SponsoredMusk’s new company could top a trillion?The investment legend who predicted the rise of Bitcoin, Facebook and streaming services like Netflix… Just...Paradigm Press | Sponsored24/7 Automated Profits in CryptoWhat if you could make consistent daily profits in crypto with minimal effort? Beyond trading lies a vast w...Crypto Swap Profits | SponsoredThe pin that pops the AI bubbleMy new documentary explores the background to this pattern and how and why I believe it will almost certainly ...Porter & Company | SponsoredCrypto’s next big bull run?Juan Villaverde may be America’s top crypto expert. And he says something big is coming for crypto – on Nov...Weiss Ratings | Sponsored“This Changes Everything” - Trump Hands Millions Massive IRS GiftNow it's your time to return the favor by taking advantage of this tax "revenge loophole." Because even as ...Colonial Metals | SponsoredTim Sykes’ Urgent Trade Alert: “Make this move now”WARNING: 80 Wall Street banks are gearing up for MASSIVE D.C. shock This $2 trillion D.C. shock is NOT abou...Timothy Sykes | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Evelo Biosciences, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Evelo Biosciences With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free EVLO Stock Alerts